Impairment of endothelium-dependent dilatation of basilar artery during chronic hypertension

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

The goal of this study was to determine whether responses of the basilar artery are altered during chronic hypertension. We measured the diameter of the basilar artery using intravital microscopy in normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). Acetylcholine (10 μM) dilated the basilar artery by 25 ± 4% (means ± SE) in WKY but by only 2 ± 2% in SHR. Bradykinin (1.0 μM) dilated the basilar artery by 12 ± 1% in WKY, but did not alter diameter in SHR (-0.1 ± 2%). In contrast, nitroglycerin produced similar vasodilatation in WKY and SHR. Next, we examined the possibility that impaired vasodilatation in SHR may be related to the production of a cyclooxygenase constrictor substance. Indomethacin (10 mg/kg iv) did not restore vasodilatation in response to acetylcholine and bradykinin in SHR. Finally, we examined the role of nitric oxide in dilatation of the basilar artery in response to acetylcholine and bradykinin in WKY. N(G)-Monomethyl-L-arginine (L-NMMA; 1.0 μM) had little effect on baseline diameter but inhibited vasodilatation in response to acetylcholine and bradykinin. Vasodilatation in response to nitroglycerin was not altered by L-NMMA. These findings suggest a profound impairment of endothelium-dependent dilatation of the basilar artery during chronic hypertension. In addition, impaired vasodilatation is not related to the production of a cyclooxygenase constrictor substance. Furthermore, dilatation of the basilar artery in WKY in response to acetylcholine and bradykinin appears to be related to the production of nitric oxide or a substance capable of liberating nitric oxide.

Original languageEnglish (US)
Pages (from-to)H1455-H1462
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume259
Issue number5 28-5
StatePublished - Jan 1 1990

Fingerprint

Basilar Artery
Inbred WKY Rats
Inbred SHR Rats
Endothelium
Dilatation
Vasodilation
Bradykinin
Hypertension
Acetylcholine
omega-N-Methylarginine
Nitric Oxide
Nitroglycerin
Prostaglandin-Endoperoxide Synthases
Indomethacin
Arginine

Keywords

  • Acetylcholine
  • Bradykinin
  • Indomethacin
  • N(G)-monomethyl- L-arginine
  • Nitroglycerin

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

@article{2e38644a376848dba7ef55b1c5da4b7d,
title = "Impairment of endothelium-dependent dilatation of basilar artery during chronic hypertension",
abstract = "The goal of this study was to determine whether responses of the basilar artery are altered during chronic hypertension. We measured the diameter of the basilar artery using intravital microscopy in normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). Acetylcholine (10 μM) dilated the basilar artery by 25 ± 4{\%} (means ± SE) in WKY but by only 2 ± 2{\%} in SHR. Bradykinin (1.0 μM) dilated the basilar artery by 12 ± 1{\%} in WKY, but did not alter diameter in SHR (-0.1 ± 2{\%}). In contrast, nitroglycerin produced similar vasodilatation in WKY and SHR. Next, we examined the possibility that impaired vasodilatation in SHR may be related to the production of a cyclooxygenase constrictor substance. Indomethacin (10 mg/kg iv) did not restore vasodilatation in response to acetylcholine and bradykinin in SHR. Finally, we examined the role of nitric oxide in dilatation of the basilar artery in response to acetylcholine and bradykinin in WKY. N(G)-Monomethyl-L-arginine (L-NMMA; 1.0 μM) had little effect on baseline diameter but inhibited vasodilatation in response to acetylcholine and bradykinin. Vasodilatation in response to nitroglycerin was not altered by L-NMMA. These findings suggest a profound impairment of endothelium-dependent dilatation of the basilar artery during chronic hypertension. In addition, impaired vasodilatation is not related to the production of a cyclooxygenase constrictor substance. Furthermore, dilatation of the basilar artery in WKY in response to acetylcholine and bradykinin appears to be related to the production of nitric oxide or a substance capable of liberating nitric oxide.",
keywords = "Acetylcholine, Bradykinin, Indomethacin, N(G)-monomethyl- L-arginine, Nitroglycerin",
author = "Mayhan, {W. G.}",
year = "1990",
month = "1",
day = "1",
language = "English (US)",
volume = "259",
pages = "H1455--H1462",
journal = "American Journal of Physiology - Renal Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "5 28-5",

}

TY - JOUR

T1 - Impairment of endothelium-dependent dilatation of basilar artery during chronic hypertension

AU - Mayhan, W. G.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - The goal of this study was to determine whether responses of the basilar artery are altered during chronic hypertension. We measured the diameter of the basilar artery using intravital microscopy in normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). Acetylcholine (10 μM) dilated the basilar artery by 25 ± 4% (means ± SE) in WKY but by only 2 ± 2% in SHR. Bradykinin (1.0 μM) dilated the basilar artery by 12 ± 1% in WKY, but did not alter diameter in SHR (-0.1 ± 2%). In contrast, nitroglycerin produced similar vasodilatation in WKY and SHR. Next, we examined the possibility that impaired vasodilatation in SHR may be related to the production of a cyclooxygenase constrictor substance. Indomethacin (10 mg/kg iv) did not restore vasodilatation in response to acetylcholine and bradykinin in SHR. Finally, we examined the role of nitric oxide in dilatation of the basilar artery in response to acetylcholine and bradykinin in WKY. N(G)-Monomethyl-L-arginine (L-NMMA; 1.0 μM) had little effect on baseline diameter but inhibited vasodilatation in response to acetylcholine and bradykinin. Vasodilatation in response to nitroglycerin was not altered by L-NMMA. These findings suggest a profound impairment of endothelium-dependent dilatation of the basilar artery during chronic hypertension. In addition, impaired vasodilatation is not related to the production of a cyclooxygenase constrictor substance. Furthermore, dilatation of the basilar artery in WKY in response to acetylcholine and bradykinin appears to be related to the production of nitric oxide or a substance capable of liberating nitric oxide.

AB - The goal of this study was to determine whether responses of the basilar artery are altered during chronic hypertension. We measured the diameter of the basilar artery using intravital microscopy in normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). Acetylcholine (10 μM) dilated the basilar artery by 25 ± 4% (means ± SE) in WKY but by only 2 ± 2% in SHR. Bradykinin (1.0 μM) dilated the basilar artery by 12 ± 1% in WKY, but did not alter diameter in SHR (-0.1 ± 2%). In contrast, nitroglycerin produced similar vasodilatation in WKY and SHR. Next, we examined the possibility that impaired vasodilatation in SHR may be related to the production of a cyclooxygenase constrictor substance. Indomethacin (10 mg/kg iv) did not restore vasodilatation in response to acetylcholine and bradykinin in SHR. Finally, we examined the role of nitric oxide in dilatation of the basilar artery in response to acetylcholine and bradykinin in WKY. N(G)-Monomethyl-L-arginine (L-NMMA; 1.0 μM) had little effect on baseline diameter but inhibited vasodilatation in response to acetylcholine and bradykinin. Vasodilatation in response to nitroglycerin was not altered by L-NMMA. These findings suggest a profound impairment of endothelium-dependent dilatation of the basilar artery during chronic hypertension. In addition, impaired vasodilatation is not related to the production of a cyclooxygenase constrictor substance. Furthermore, dilatation of the basilar artery in WKY in response to acetylcholine and bradykinin appears to be related to the production of nitric oxide or a substance capable of liberating nitric oxide.

KW - Acetylcholine

KW - Bradykinin

KW - Indomethacin

KW - N(G)-monomethyl- L-arginine

KW - Nitroglycerin

UR - http://www.scopus.com/inward/record.url?scp=0025085849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025085849&partnerID=8YFLogxK

M3 - Article

C2 - 2122745

AN - SCOPUS:0025085849

VL - 259

SP - H1455-H1462

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 0363-6127

IS - 5 28-5

ER -